<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01572116</url>
  </required_header>
  <id_info>
    <org_study_id>IRCT201110137790N1</org_study_id>
    <nct_id>NCT01572116</nct_id>
  </id_info>
  <brief_title>Effect of Sufentanil on the Rate of Anesthesia</brief_title>
  <official_title>Comparison the Effect of Lidocaine (With Epinephrine) With and Without Sufentanil on the Rate of Anesthesia of Intra-ligamentary Injection in Teeth With Irreversible Pulpitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Islamic Azad University, Tehran</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Islamic Azad University, Tehran</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study was to compare the effects of Lidocaine/epinephrine with and without
      Sufentanil on the rate of anesthesia after supplemental intraligamentary injection (PDL) in
      teeth with irreversible pulpitis.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2010</start_date>
  <completion_date type="Actual">October 2011</completion_date>
  <primary_completion_date type="Actual">June 2011</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>depth of anesthesia</measure>
    <time_frame>in different times such as :before the treatment,and during the treatment in these times: 1,5,9,13,17 minutes after starting the treatment</time_frame>
    <description>The measuring method of the pain is Electric pulp tester</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>intensity of the pain</measure>
    <time_frame>before the treatment,Immediately after treatment, from commencement of treatment until complete pulpotomy stage, from commencement of treatment until initial file determination ,from commencement of treatment until end of pulpectomy</time_frame>
    <description>The measuring method of the pain is Visual mentreatAnalogue Scale (VAS 0-170 mm)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Irreversible Pulpitis</condition>
  <arm_group>
    <arm_group_label>Lidocaine with Epinephrine+ Normal saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Lidocaine with Epinephrine + sufentanil</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine with Epinephrine+ Normal saline</intervention_name>
    <description>PDL injection of 0/4 ml of lidocaine %2 with epinephrine,and Normal saline</description>
    <arm_group_label>Lidocaine with Epinephrine+ Normal saline</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine with Epinephrine + sufentanil</intervention_name>
    <description>PDL injection of 0/4 ml lidocaine with epinephrine and0/4 ml sufentanil ( 0/04 Î¼g)</description>
    <arm_group_label>Lidocaine with Epinephrine + sufentanil</arm_group_label>
    <other_name>Brand name:Sufenta</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients in the age group of 18-65 years old

          -  healthy (ASA I, II)

          -  patients with first or second mandibular molars who need endodontic treatment

          -  vital tooth without a history of past endodontic treatment

          -  patients with clinical evidence of irreversible Pulpits with moderate to severe pain

          -  patients who signed consent form

          -  patients numbness at the lateral edge of the lips after inferior alveolar injection
             (INA) and those with positive respond to maximum output of pulp tester after INA.

        Exclusion Criteria:

          -  pregnant or nursing

          -  necrotic tooth

          -  patients with allergy or contraindication toward non-opioid or opioid painkillers such
             as aspirin or NSAIDs

          -  Patients who have taken opioid or non opioid or steroid pain killers, antidepressants
             or sedative drugs in the past 48 hours

          -  patient with infectious diseases

          -  patient with moderate to sever periodontal disease

          -  those without numbness at the lateral edge of the lips after inferior alveolar
             injection (INA), and those do not respond to maximum output of pulp tester after INA.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mandana Abedi Tari, Dentist</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dental School of Azad University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dental School of Azad University</name>
      <address>
        <city>Tehran</city>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>April 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 3, 2012</study_first_submitted>
  <study_first_submitted_qc>April 4, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 6, 2012</study_first_posted>
  <last_update_submitted>April 4, 2012</last_update_submitted>
  <last_update_submitted_qc>April 4, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 6, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Islamic Azad University, Tehran</investigator_affiliation>
    <investigator_full_name>Mandana Abedi Tari</investigator_full_name>
    <investigator_title>principal investigator</investigator_title>
  </responsible_party>
  <keyword>sufentanil</keyword>
  <keyword>irreversible pulpitis</keyword>
  <keyword>intra ligament injection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulpitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Sufentanil</mesh_term>
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Racepinephrine</mesh_term>
    <mesh_term>Epinephryl borate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

